Xin Hang

Investor

Senior Principal at CTI Life Sciences Fund L.P.

About

Xin Hang is a Senior Principal whose Sanofi manufacturing experience and valuation work—leading forecasting for Point Biopharma’s SPAC and Horizon’s Amgen deal—combine technical and financial drug‑development expertise.

Invests in

BiotechHealthtechMedical Devices

Colleagues at CTI Life Sciences Fund L.P.

Dana Matzen

Partner at CTI Life Sciences Fund L.P.

Ken Pastor

Managing Partner at CTI Life Sciences Fund L.P.

Laurence Rulleau

Managing Partner at CTI Life Sciences Fund L.P.

Paul Cassar

Associate at CTI Life Sciences Fund L.P.

Radhika Gupta

Principal at CTI Life Sciences Fund L.P.

Shermaine Tiley

Managing Partner at CTI Life Sciences Fund L.P.

Shermaine Tilley

Managing Partner at CTI Life Sciences Fund L.P.

Youssef Bennani

Managing Partner at CTI Life Sciences Fund L.P.